Companies / Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc.
Insider flow · last 90 daysNet sells $469.1K
Financials · FY2025
Ownership
64.9M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.50% | 975,972 |
| Institutions | 97.83% | 63,521,393 |
| Public float | 0.67% | 434,838 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Heron Patrick JDirector | 0.71% | 459,010 |
Peetz ChristopherCEOCHIEF EXECUTIVE OFFICER · Director | 0.59% | 381,809 |
Bjerkholt EricCHIEF FINANCIAL OFFICER | 0.07% | 47,181 |
Radovich PeterPRESIDENT AND COO | 0.06% | 40,272 |
Quan JoanneCHIEF MEDICAL OFFICER | 0.03% | 18,864 |
Fischer LaurentDirector | 0.02% | 10,727 |
Walbert Timothy PDirector | 0.01% | 9,680 |
Howe JolandaSVP, GLOBAL CONTROLLER | 0.01% | 8,429 |
Ramasastry SairaDirector | 0.00% | 0 |
Brege LauraDirector | — | — |
Institutional holders 293
View all →| Holder | Value | % of shares |
|---|---|---|
| $641.76M | 10.70% | |
| $536.75M | 10.46% | |
| $513.94M | 6.76% | |
| $254.12M | 3.34% | |
| $205.07M | 4.00% | |
| $165.37M | 3.22% | |
| $146.40M | 2.44% | |
| $122.40M | 2.04% | |
| $116.42M | 1.94% | |
| $114.18M | 1.90% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Heron Patrick J Director | Buy | Common Stock | $9.00M | +131K +40.12% | 459,010 0.71% of shares | high |
| Mar 16, 2026 | Peetz Christopher CEO | Sell | Common Stock | $3.77M | -41K -17.42% | 194,309 0.30% of shares | medium |
| Mar 16, 2026 | Radovich Peter Executive | Sell | Common Stock | $1.52M | -17K -29.08% | 40,272 0.06% of shares | medium |
| Feb 2, 2026 | Peetz Christopher CEO | Sell | Common Stock | $940.9K | -9K -5.38% | 160,294 0.25% of shares | medium |
| Mar 16, 2026 | Quan Joanne Executive | Sell | Common Stock | $670.2K | -7K -27.87% | 18,864 0.03% of shares | medium |
| Mar 16, 2026 | Bjerkholt Eric Executive | Sell | Common Stock | $670.2K | -7K -12.77% | 49,788 0.08% of shares | medium |
| Jan 22, 2026 | Peetz Christopher CEO | Sell | Common Stock | $662.4K | -7K -4.15% | 163,733 0.25% of shares | medium |
| Jan 26, 2026 | Peetz Christopher CEO | Sell | Common Stock | $657.1K | -7K -3.88% | 169,402 0.26% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
| Eventide Asset Management, LLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| MIRM | — | 604749101 |